BIO-key International Inc...

NASDAQ: BKYI · Real-Time Price · USD
0.74
-0.01 (-0.67%)
At close: Aug 15, 2025, 10:00 AM

BIO-key International Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.7M 1.61M 1.46M 2.14M 1.14M 2.18M 925.1K 1.82M 1.93M 3.08M 1.76M 1.37M 1.95M 1.94M 934.93K 1.3M 992.09K 1.89M
Cost of Revenue
464.18K 279.5K 262.36K 465.11K 262.27K 299.64K 4.42M 426.6K 606.11K 820.27K 584.39K 393.78K 723.95K 337.44K 372.05K 294.67K 239.57K 766.63K
Gross Profit
1.23M 1.33M 1.2M 1.68M 879.01K 1.88M -3.5M 1.4M 1.32M 2.26M 1.17M 979.77K 1.22M 1.6M 562.88K 1M 752.52K 1.12M
Operating Income
-1.08M -640.64K -1.27M -580.4K -1.65M -508.93K -6.52M -1.97M -1.18M -308.4K -4.76M -2.4M -1.72M -999.53K -2M -993.98K -1.11M -716.05K
Interest Income
2.09K 3.00 57.00 n/a 46.00 5.00 5.59K 5.92K 23.00 4.00 17.00 8.00 77.00 131.00 299.00 329.00 832.00 2.62K
Pretax Income
-1.17M -736.54K -1.41M -738.96K -1.67M -510.29K -6.45M -1.84M -1.28M -526.47K -5.11M -2.4M -1.72M -999.4K -2.03M -1.02M -1.16M -731.43K
Net Income
-1.17M -736.54K -1.57M -738.96K -1.67M -510.29K -6.17M -1.84M -1.42M -625.47K -5.43M -2.4M -1.72M -999.27K -2.03M -1.02M -1.16M -731.43K
Selling & General & Admin
1.68M 1.37M 1.81M 1.61M 1.94M 1.78M 2.44M 1.59M 1.94M 1.88M 3.33M 2.51M 2.01M 1.8M 1.75M 1.39M 1.37M 1.4M
Research & Development
636.03K 595.77K 660.15K 652.17K 591.23K 607.52K 587.9K 558.69K 558.18K 690.16K 833.38K 829.51K 784.08K 805.27K 809.86K 612.6K 490.95K 441.65K
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 262.82K 40K 150K n/a 30K 30K n/a n/a
Operating Expenses
2.32M 1.97M 2.47M 2.26M 2.53M 2.39M 3.03M 2.15M 2.5M 2.57M 4.42M 3.38M 2.94M 2.6M 2.59M 2.03M 1.87M 1.84M
Interest Expense
85.64K 95.91K 126.93K 158.56K 12.91K 1.36K 58.89K 45.66K 56.81K 56.92K 26.34K 2.07K 1.54K n/a n/a n/a n/a 18K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 497.27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.78M 2.25M 2.73M 2.73M 2.8M 2.69M 7.45M 3.78M 3.11M 3.39M 5.01M 3.77M 3.66M 2.94M 2.96M 2.32M 2.1M 2.6M
Income Tax Expense
n/a n/a -23K n/a n/a n/a -276.82K -189 143K 99K 321.48K 2.06K 1.46K -131 299.00 n/a n/a -76.52K
Shares Outstanding (Basic)
5.82M 4.7M 3.03M 1.89M 1.66M 1.62M 1.09M 570.75K 556.76K 480.83K 457.2K 452.71K 449.89K 438.06K 433.2K 432.82K 432.01K 431.87K
Shares Outstanding (Diluted)
5.82M 4.7M 3.03M 1.89M 1.66M 1.62M 1.09M 570.75K 556.76K 480.83K 457.2K 452.71K 449.89K 438.06K 433.2K 432.82K 432.01K 431.87K
EPS (Basic)
-0.2 -0.16 -0.52 -0.39 -1 -0.32 -5.67 -3.22 -2.56 -1.3 -11.88 -5.31 -3.82 -2.28 -4.68 -2.37 -2.69 -1.69
EPS (Diluted)
-0.2 -0.16 -0.52 -0.39 -1 -0.32 -5.67 -3.22 -2.56 -1.3 -11.88 -5.31 -3.82 -2.28 -4.68 -2.37 -2.69 -1.69
EBITDA
-1.08M -640.64K -1.17M -479.99K -1.55M -407.12K -6.2M -490.83K -2.28M -1.66M -4.88M -2.28M -1.64M -863.64K -1.91M -951.07K -1.11M -754.3K
EBIT
-1.08M -640.63K -1.34M -516.4K -1.66M -508.93K -6.39M -1.79M -2.42M -1.63M -6.8M -2.4M -1.7M -999.53K -2.03M -1.02M -1.16M -833.43K
Depreciation & Amortization
n/a 98.03K 175.15K 100.42K 100.16K 101.81K 187.06K 101.53K 140.94K 160.61K 207.49K 163.03K 58.45K 117.04K 122.51K 123.69K 124.04K 136.25K